David Karli is a physician, entrepreneur and biomedical thought leader. He is the CEO and owner of Greyledge Technologies, an emerging biotechnology company focused on developing stem cell and biologic therapies. He has been active in developing stem cell science both scientifically and clinically since 2005, personally involved in treating thousands of patients to date, including numerous elite-level and professional athletes. In addition, he maintains executive and consulting roles within the biotech, sports medicine, fitness, age management and wellness business sectors. He continues to lead the effort required to refine the practice of regenerative medicine, and has published pivotal clinical results and lectured extensively. Dr. Karli has been featured in high-level media publications such as the Wall Street Journal, New York Times, ESPN Magazine and Denver Magazine.